Cargando…
Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations
The early and specific detection of tumors remains a barrier in oncology, especially in cases such as the triple-negative breast cancer (TNBC). To address this gap, aptamers have found an important application in the recognition of tumor biomarkers such as mucin 1 (MUC1). However, there are still so...
Autores principales: | Santos do Carmo, Fagner, Ricci-Junior, Eduardo, Cerqueira-Coutinho, Cristal, Albernaz, Marta de Souza, Bernardes, Emerson Soares, Missailidis, Sotiris, Santos-Oliveira, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191850/ https://www.ncbi.nlm.nih.gov/pubmed/28053523 http://dx.doi.org/10.2147/IJN.S118482 |
Ejemplares similares
-
Development, Characterization, and In Vivo Evaluation of a Novel Aptamer (Anti-MUC1/Y) for Breast Cancer Therapy
por: Khan, Huma, et al.
Publicado: (2021) -
Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
por: Da Pieve, C, et al.
Publicado: (2006) -
Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
por: Da Pieve, C, et al.
Publicado: (2008) -
Application of Aptamer-Based Assays to the Diagnosis of Arboviruses Important for Public Health in Brazil
por: Argondizzo, Ana Paula Corrêa, et al.
Publicado: (2020) -
Phototoxic aptamers selectively enter and kill epithelial cancer cells
por: Ferreira, Cátia S. M., et al.
Publicado: (2009)